Climb Bio, Inc. Share Price
CLYMClimb Bio, Inc. Stock Performance
Open $1.90 | Prev. Close $1.90 | Circuit Range N/A |
Day Range $1.90 - $1.96 | Year Range $1.09 - $4.09 | Volume 7,194 |
Average Traded $1.93 |
Climb Bio, Inc. Share Price Chart
About Climb Bio, Inc.
Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases. The company develops budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug IV for the treatment of primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN). The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts.
Climb Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $1.90 | $1.92 | +0.00% |
12-Nov-25 | $1.90 | $1.92 | +0.79% |
11-Nov-25 | $1.87 | $1.90 | +5.85% |
10-Nov-25 | $1.89 | $1.79 | -1.91% |
07-Nov-25 | $1.89 | $1.83 | -5.91% |
06-Nov-25 | $1.89 | $1.95 | +1.57% |
05-Nov-25 | $1.90 | $1.92 | +1.86% |
FAQs on Climb Bio, Inc. Share Price
Can I buy Climb Bio, Inc. shares in India?
What is the share price of Climb Bio, Inc.?
What is the 5 year returns of Climb Bio, Inc.?
What are the high & low stock price of Climb Bio, Inc. today?
What is the 52-week high and low of Climb Bio, Inc. stock?